Financial Performance - Operating revenue for the first quarter reached CNY 2,712,983,676.41, representing a 17.08% increase year-on-year[11] - Net profit attributable to shareholders was a loss of CNY 57,199,898.96, a decrease of 185.74% compared to the same period last year[11] - Basic and diluted earnings per share were both CNY -0.035, down 185.37% from CNY 0.041 in the same period last year[11] - The company reported a net profit of ¥175,194,388.56, compared to ¥232,394,287.52 in the previous period, indicating a decrease of about 24.6%[35] - The company reported a total comprehensive income for Q1 2021 was a loss of CNY 53,645,616.91, compared to a gain of CNY 62,310,022.73 in Q1 2020[49] - The company's operating profit for Q1 2021 was a loss of CNY 36,075,482.52, down from a profit of CNY 75,199,721.63 in Q1 2020[46] Assets and Liabilities - Total assets increased by 3.40% to CNY 24,744,558,685.66 compared to the end of the previous year[11] - The company's total current assets reached RMB 12,920,656,492.17, an increase from RMB 12,111,289,119.04 in the previous year[30] - Current liabilities rose to ¥13,253,749,910.37, compared to ¥11,753,326,122.54, indicating an increase of about 12.7%[33] - Non-current liabilities due within one year increased by 52.05% to RMB 2,057,884,983.31, primarily due to the transfer of long-term borrowings[21] - Total liabilities increased to CNY 13,372,209,884.02 in Q1 2021 from CNY 12,935,735,293.63 in Q1 2020, an increase of 3.4%[50] Cash Flow - Net cash flow from operating activities decreased by 19.88% to CNY 42,262,764.11 compared to the previous year[11] - The net cash flow from financing activities decreased by 74.45% to RMB 607,204,573.27, reflecting a reduction in new loans compared to the previous year[24] - Cash received from tax refunds increased by 133.65% to RMB 55,432,346.84, driven by increased export tax rebates[24] - The net cash flow from operating activities for Q1 2021 was CNY 275,240,759.57, up from CNY 248,069,821.49 in the same period last year, reflecting a growth of approximately 11%[59] Shareholder Information - The total number of shareholders at the end of the reporting period was 105,151[18] - The largest shareholder, Jizhong Energy Co., Ltd., holds 25.33% of the shares[18] Expenses - Management expenses rose by 82.68% to RMB 189,663,092.94, largely impacted by the COVID-19 situation in Shijiazhuang[24] - Research and development expenses increased by 49.90% to RMB 28,364,300.05, indicating a stronger focus on R&D efforts[24] - Sales expenses surged to CNY 265.18 million in Q1 2021, compared to CNY 102.68 million in Q1 2020, highlighting increased marketing efforts[51] - Financial expenses, including interest expenses, rose to CNY 105.07 million in Q1 2021, compared to CNY 84.17 million in Q1 2020, indicating higher borrowing costs[51] Market Strategy - The company has not disclosed any new product developments or market expansion strategies in this report[11] - The company plans to expand its market presence and invest in new product development to drive future growth[34] - The company aims to continue expanding its market presence and investing in new technologies to drive future growth[52] Leasing Standards - The company has implemented new leasing standards effective from January 1, 2021, impacting the recognition of right-of-use assets and lease liabilities[112] - The company chose not to reassess existing contracts under the new leasing standards, opting for a simplified retrospective adjustment method[120] - The company confirmed that it will treat leases completed within 12 months post-January 1, 2021, as short-term leases[120]
华北制药(600812) - 2021 Q1 - 季度财报